| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -6.8e-05 | 1 |